MARKETS, STOCKS

Bruce Kaser

Chief Analyst,

Cabot Undervalued Stocks Advisor

  • President and CIO at Rohenth Capital Research
  • 25 Years Industry Expertise
  • Chief Analyst, Cabot Turnaround Letter and Cabot Undervalued Stocks Advisor

About Bruce

Bruce Kaser has more than 25 years of value investing experience in managing institutional portfolios, mutual funds, and private client accounts. He has led two successful investment platform turnarounds, co-founded an investment management firm, and was principal of a $3 billion (AUM) employee-owned investment management company, New Generation Research. Prior, Mr. Kaser led the event-driven small/midcap strategy for Ironwood Investment Management and was senior portfolio manager with RBC Global Asset Management where he co-managed the $1 billion value/core equity platform for over a decade. He earned his MBA degree, in finance and international business, from the University of Chicago and did his undergraduate studies in finance, with honors from Miami University (Ohio). Mr. Kaser is now chief analyst of Cabot Undervalued Stocks Advisor.

Bruce's Articles

Molson Coors Beverage Company (TAP) is one of the world’s largest beverage companies, producing the highly recognized Coors, Molson, Miller and Blue Moon brands as well as numerous local, craft and specialty beers, explains Bruce Kaser, editor of Cabot Undervalued Stocks Advisor.
Our interest in oil and natural gas exploration and production (E&P) companies has been warming up lately. Many of these stocks are beaten down, yet oil prices have remained resilient, leaving producers like ConocoPhillips (COP) meaningfully undervalued, notes Bruce Kaser, editor of Cabot Undervalued Stocks Advisor.
Bristol Myers Squibb Company (BMY) sells at a low valuation due to worries over patent expirations for Revlimid (starting in 2022) and Opdivo and Eliquis (starting in 2026), observes Bruce Kaser, editor of Cabot Undervalued Stocks Advisor.
Walgreens Boots Alliance (WBA) is the largest retail pharmacy chain in the United States and Europe, with over 21,000 Walgreens and Boots stores in 11 countries, notes Bruce Kaser, editor of Cabot Turnaround Letter.

Bruce's Videos

The time and patience to trade turnarounds
Buying out-of-favor stocks supported by deep fundamental analysis is becoming a lost art. This presentation will show you the tools and methods used by New Generation Research/The Turnaround Letter for finding stocks that can produce outsized returns.

Buying out-of-favor stocks supported by deep fundamental analysis is becoming a lost art. This presentation will show you the tools and methods used by New Generation Research/The Turnaround Letter for finding stocks that can produce outsized returns.